SYRE
Price
$15.49
Change
+$0.19 (+1.24%)
Updated
Apr 2 closing price
Capitalization
933.38M
35 days until earnings call
ZVSA
Price
$0.59
Change
-$0.00 (-0.00%)
Updated
Apr 3, 10:45 AM (EDT)
Capitalization
1.47M
Ad is loading...

SYRE vs ZVSA

Header iconSYRE vs ZVSA Comparison
Open Charts SYRE vs ZVSABanner chart's image
Spyre Therapeutics
Price$15.49
Change+$0.19 (+1.24%)
Volume$586.35K
Capitalization933.38M
ZyVersa Therapeutics
Price$0.59
Change-$0.00 (-0.00%)
Volume$700
Capitalization1.47M
SYRE vs ZVSA Comparison Chart
Loading...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZVSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SYRE vs. ZVSA commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SYRE is a Hold and ZVSA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (SYRE: $15.49 vs. ZVSA: $0.59)
Brand notoriety: SYRE and ZVSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SYRE: 85% vs. ZVSA: 27%
Market capitalization -- SYRE: $933.38M vs. ZVSA: $1.47M
SYRE [@Biotechnology] is valued at $933.38M. ZVSA’s [@Biotechnology] market capitalization is $1.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SYRE’s FA Score shows that 0 FA rating(s) are green whileZVSA’s FA Score has 1 green FA rating(s).

  • SYRE’s FA Score: 0 green, 5 red.
  • ZVSA’s FA Score: 1 green, 4 red.
According to our system of comparison, ZVSA is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SYRE’s TA Score shows that 4 TA indicator(s) are bullish while ZVSA’s TA Score has 4 bullish TA indicator(s).

  • SYRE’s TA Score: 4 bullish, 4 bearish.
  • ZVSA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, ZVSA is a better buy in the short-term than SYRE.

Price Growth

SYRE (@Biotechnology) experienced а -8.99% price change this week, while ZVSA (@Biotechnology) price change was -20.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.69%. For the same industry, the average monthly price growth was -9.74%, and the average quarterly price growth was -14.08%.

Reported Earning Dates

SYRE is expected to report earnings on May 08, 2025.

ZVSA is expected to report earnings on Apr 12, 2023.

Industries' Descriptions

@Biotechnology (-7.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($933M) has a higher market cap than ZVSA($1.47M). SYRE has higher P/E ratio than ZVSA: SYRE (1.72) vs ZVSA (0.00). SYRE YTD gains are higher at: -33.462 vs. ZVSA (-44.594). ZVSA has higher annual earnings (EBITDA): -9.62M vs. SYRE (-208.57M). SYRE has more cash in the bank: 603M vs. ZVSA (123K). SYRE (0) and ZVSA (0) have identical debt. SYRE (0) and ZVSA (0) have equivalent revenues.
SYREZVSASYRE / ZVSA
Capitalization933M1.47M63,340%
EBITDA-208.57M-9.62M2,169%
Gain YTD-33.462-44.59475%
P/E Ratio1.720.00135,838%
Revenue00-
Total Cash603M123K490,244%
Total Debt00-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
80
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SYREZVSA
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 11 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZVSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIVHX17.510.02
+0.11%
American Funds International Vntg R-2E
MGQSX16.69N/A
N/A
Morgan Stanley Inst Global Stars R6
GITSX23.43N/A
N/A
Goldman Sachs Technology Opps Svc
VRVIX322.18N/A
N/A
Vanguard Russell 1000 Value Index I
ICERX40.98-0.08
-0.19%
NYLI Epoch International Chc SIMPLE Cl

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with BEAM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
+1.27%
BEAM - SYRE
48%
Loosely correlated
+4.79%
APGE - SYRE
47%
Loosely correlated
+6.23%
CGON - SYRE
46%
Loosely correlated
+0.86%
PRME - SYRE
46%
Loosely correlated
+0.28%
IDYA - SYRE
46%
Loosely correlated
+10.70%
More